Formycon AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Formycon AG with three other
companies in this sector in Germany:
sales of 4.14 million Euro [US$4.51 million]
of which 100%
Mevis Medical Solutions AG
(16.01 million Euro [US$17.44 million]
of which 78%
was Digital Mammography), and
Brain Biotechnology Research and Information Network AG
(23.92 million Euro [US$26.05 million]
of which 0%
Formycon AG reported sales of 17.15 million Euro (US$18.69 million)
December of 2015.
increase of 35.4%
versus 2014, when the company's sales were 12.67 million Euro.